The latest gynaecological cancer news
Researchers from Hebrew University-Hadassah in Jerusalem, Israel, and Cardioinfantil Foundation, Cardiology Institute in Bogota, Colombia,…
Highlights on maintenance olaparib in ovarian cancer previously treated with PARPi
Highlights on aspirin use in recurrent platinum-resistent ovarian cancer: EORTC-1508 study
Highlights on a phase I of dual RAF/MEK inhibitor + FAK inhibitor in ovarian cancer…
The addition of immunotherapy to standard first-line treatment extends survival by eight months for patients…
A recent trend analysis indicates that cervical cancer incidence and mortality rates have remained stable…
Researchers at Southern Methodist University, USA, have found a way to make chemotherapy drugs more…
Ovarian cancer devastates more than 20,000 women in the U.S. every year, due in part…
A gene called DOT1L appears to play a role in progression and severity of ovarian…
UT Southwestern faculty (USA) have discovered what appears to be an Achilles’ heel in ovarian…